
Analysts Viewpoint
Morgan Stanley gives an Overweight recommendation for Axsome Therapeutics Inc (AXSM)
Axsome Therapeutics Inc’s filing revealed that its General Counsel Murdock Hunter R. unloaded Company’s shares for reported $0.77 million on